CIK: 0001664974 · Show all filings
Period: Q4 2022 (← Previous) (Next →)
Filing Date: Feb 14, 2023
Total Value ($000): $95,216 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RXRX | Recursion Pharmaceuticals, Inc. | 5,941,120 | $45,806 | 48.1% | $18.82 | -47.9% | COM CL A | 75629V104 |
| EVLV | Evolv Technologies | 10,601,281 | $27,457 | 28.8% | $5.61 | -47.5% | COM CL A | 30049H102 |
| — | Rocket Lab USA, Inc. | 2,929,350 | $11,044 | 11.6% | $12.28 | — | COM | 773122956 |
| — | Embark Trucks, Inc. | 3,186,008 | $10,482 | 11.0% | $7.43 | — | COM NEW | 29079J202 |
| — | Mind Medicine (MindMed) Inc. | 100,350 | $221 | 0.2% | $1.73 | — | COM SUB VTG | 60255C109 |
| ROIV | Roivant Sciences Ltd. | 25,840 | $206 | 0.2% | $5.56 | 0.0% | SHS | G76279101 |